NASDAQ : PYPD
PolyPid Ltd. — Key statistics
Healthcare · Biotechnology · Israel
Last price 5.39 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 109.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 110.09M |
| Enterprise Value | 105.10M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 20.31M |
| Shares Outstanding | 20.31M |
| Shares Change (YoY) | +121.57% |
| Shares Change (QoQ) | +3.25% |
| Owned by Insiders (%) | 7.42% |
| Owned by Institutions (%) | 12.06% |
| Float | 12.16M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 4.66 |
| PB Ratio | 20.32 |
| P/TBV Ratio | 20.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.35 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -168.95 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -243.59% |
| Return on Assets (ROA) | -74.63% |
| Return on Invested Capital (ROIC) | -109.38% |
| Return on Capital Employed (ROCE) | -366.05% |
| Weighted Average Cost of Capital (WACC) | 11.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$420,013 |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -53,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +41.51% |
| 50-Day Moving Average | 5.20 |
| 200-Day Moving Average | 4.73 |
| Relative Strength Index (RSI) | 55.44 |
| Average Volume (20 Days) | 120,292 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 225,458 |
| Short Previous Month | 126,220 |
| Short % of Shares Out | 1.11% |
| Short % of Float | 1.85% |
| Short Ratio (days to cover) | 2.56 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.59M |
| Pretax Income | -31.55M |
| Net Income | -31.50M |
| EBITDA | -30.12M |
| EBIT | -31.59M |
| Earnings Per Share (EPS) | -$1.48 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 6.56M |
| Total Debt | 1.57M |
| Net Cash | 4.99M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 5.39M |
| Book Value Per Share | 0.27 |
| Working Capital | 2.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -29.00M |
| Capital Expenditures | -402,000 |
| Depreciation & Amortization | 1.48M |
| Net Borrowing | -5.75M |
| Free Cash Flow | -29.41M |
| FCF Per Share | -$1.45 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -121.57% |
| Shareholder Yield | -121.57% |
| Earnings Yield | -27.24% |
| FCF Yield | -26.76% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $11.40 |
| Price Target Difference | 110.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 21, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |